Insmed Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 7.45, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Insmed Inc in Sep 30 2026 quarter, has decreased to 49 days, compared to 51 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 212 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1952, from overall ranking in the second quarter 2026 at 2121.

What is Receivable Turnover Ratio?
What is Insmed Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INSM Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	297.29 %	291.27 %	273.97 %	170.82 %	54.21 %
Y / Y Revenue Change	330 %	393.78 %	301.22 %	287.83 %	77.99 %
Receivable Turnover Ratio (TTM)	7.45	7.18	6.71	6.77	6.22
INSM's Total Ranking	# 1952	# 2121	# 726	# 2597	#
Accounts Receivable average collection period days	49	51	54	54	59
Seq. Receivable Change	20.41 %	20.59 %	26.76 %	115.84 %	18.58 %
Seq. Revenue Change	23.25 %	48.83 %	17.53 %	99.45 %	41.53 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 68
Healthcare Sector	# 213
Overall Market	# 1952

Receivable Turnover Ratio Statistics
High	Average	Low
10.39	8.55	5.86
(Mar 31 2021)		(Jun 30 2025)

INSM Company Profile • Back to INSM Efficiency Comparisons • Compare INSM Receivables Turnover Ratio to its Competitors

Financial Statements
Insmed Inc's Accounts Receivable	$ 259 Millions	Visit INSM's Balance sheet
Insmed Inc's Sales TTM	$ 1,479 Millions	Visit INSM's Income Statement
Sources of INSM's Revenues		Visit INSM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
INSM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
INSM's Growth Rates	INSM's Roa	INSM's Inventory Turnover Ratio	INSM's Dividend Comparisons
INSM's Profitability Ratios	INSM's Roi	INSM's Asset Turnover Ratio	INSM's Dividend Growth
INSM's Valuation Ratios	INSM's Roe	INSM's Financial Strength Ratios	INSM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Biogen Inc	15.19	$ 10,297.300 Millions	$ 677.900 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Medpace Holdings Inc	6.73	$ 2,838.385 Millions	$ 421.525 Millions
3m Company	6.59	$ 25,247.000 Millions	$ 3,832.500 Millions
Healthcare Services Group Inc	6.36	$ 1,879.860 Millions	$ 295.784 Millions
Integra Lifesciences Holdings Corp	6.26	$ 1,656.786 Millions	$ 264.861 Millions
Neogen Corporation	6.17	$ 884.120 Millions	$ 143.371 Millions
Mimedx Group Inc	6.06	$ 303.363 Millions	$ 50.077 Millions
Avantor Inc	5.98	$ 6,635.600 Millions	$ 1,110.300 Millions
Conmed Corporation	5.76	$ 1,369.288 Millions	$ 237.544 Millions
Clearpoint Neuro Inc	5.75	$ 45.493 Millions	$ 7.906 Millions
Johnson and Johnson	5.45	$ 99,335.000 Millions	$ 18,233.000 Millions
Biomerica Inc	5.17	$ 4.338 Millions	$ 0.838 Millions
Ge Healthcare Technologies Inc	5.11	$ 19,878.000 Millions	$ 3,886.750 Millions
Bausch and Lomb Corp	4.68	$ 5,418.000 Millions	$ 1,158.500 Millions
Orthopediatrics Corp	4.61	$ 263.665 Millions	$ 57.191 Millions
Cryo cell International Inc	4.54	$ 31.127 Millions	$ 6.851 Millions
Glaukos Corp	4.47	$ 578.355 Millions	$ 129.301 Millions
Medinotec Inc	4.05	$ 10.211 Millions	$ 2.524 Millions
Amarin Corp Plcuk	1.50	$ 176.609 Millions	$ 118.128 Millions

Date modified: 2026-10-30T10:05:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.